Jalen Green: Everything you need to know

Jalen Green

#4 SG

Phoenix Suns

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

19.9

4.2

3.3

0.3

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	32	27	25.9	17.8	3.6	2.8	0.3	1.1	2.3	0	0	2.2	7.1	31.3%	4.5	8.9	50.9%	6.8	16.0	42.2%	2.0	2.7	74.7%	0.5	3.1	1.3	1.3	+32	51.6%
2024-25	82	82	32.9	21.0	4.6	3.4	0.3	0.9	2.5	4	0	2.9	8.1	35.4%	4.6	9.5	48.2%	7.4	17.5	42.3%	3.3	4.1	81.3%	0.5	4.0	1.5	1.4	+166	54.4%
2023-24	82	82	31.7	19.6	5.2	3.5	0.3	0.8	2.3	7	1	2.5	7.4	33.2%	4.4	8.9	49.8%	6.9	16.2	42.3%	3.5	4.3	80.4%	0.5	4.7	1.4	1.5	+31	54.1%
2022-23	76	76	34.2	22.1	3.7	3.7	0.2	0.8	2.6	0	0	2.5	7.3	33.8%	5.0	10.6	47.1%	7.4	17.9	41.6%	4.8	6.1	78.6%	0.6	3.2	1.7	1.4	-447	53.8%
2021-22	67	67	31.9	17.3	3.4	2.6	0.3	0.7	2.0	0	0	2.3	6.8	34.3%	3.7	7.4	50.2%	6.1	14.2	42.6%	2.8	3.5	79.7%	0.5	2.9	1.5	1.3	-519	54.7%
Career	339	334	32.1	19.9	4.2	3.3	0.3	0.8	2.4	11	1	2.5	7.4	33.9%	4.5	9.1	48.9%	7.0	16.5	42.2%	3.5	4.3	79.6%	0.5	3.7	1.5	1.4	-737	54.0%

Career Averages

PTS

REB

AST

BLK

STL

13.3

5.4

2.9

0.3

0.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	7	7	31.3	13.3	5.4	2.9	0.3	0.6	1.4	0	0	1.9	6.3	29.5%	2.7	6.0	45.2%	4.6	12.3	37.2%	2.3	3.4	66.7%	0.4	5.0	0.9	2.0	+23	48.2%
Career	7	7	31.3	13.3	5.4	2.9	0.3	0.6	1.4	0	0	1.9	6.3	29.5%	2.7	6.0	45.2%	4.6	12.3	37.2%	2.3	3.4	66.7%	0.4	5.0	0.9	2.0	+23	48.2%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/8	DAL	W 112-107	3	0	1	0	0	0	0	1	0	0.0%	1	0	0.0%	2	0	0.0%	0	0	0.0%	0	1	0.0	-1	0	1	0.0%
4/7	HOU	L 119-105	31	15	3	1	4	0	3	4	0	0.0%	10	5	50.0%	14	5	35.7%	7	5	71.4%	0	3	0.3	-5	3	11	43.9%
4/5	CHI	W 120-110	36	25	4	4	0	1	6	7	2	28.6%	14	9	64.3%	21	11	52.4%	2	1	50.0%	0	4	0.7	+8	4	16	57.1%
4/2	CHA	L 127-107	34	25	4	7	1	2	3	6	3	50.0%	13	7	53.8%	19	10	52.6%	2	2	100.0%	1	3	2.3	-11	1	25	62.9%
3/31	ORL	L 115-111	19	8	1	2	0	2	4	5	0	0.0%	5	3	60.0%	10	3	30.0%	2	2	100.0%	1	0	0.5	+2	1	3	36.8%
3/30	MEM	W 131-105	24	21	6	1	0	2	1	7	3	42.9%	11	6	54.5%	18	9	50.0%	0	0	0.0%	2	4	1.0	+1	3	18	58.3%
3/28	UTA	W 134-109	22	31	6	3	0	0	0	11	5	45.5%	11	8	72.7%	22	13	59.1%	0	0	0.0%	1	5	0.0	+9	1	29	70.5%
3/24	DEN	L 125-123	29	21	6	6	0	0	2	6	3	50.0%	7	3	42.9%	13	6	46.2%	8	6	75.0%	0	6	3.0	+9	2	25	63.6%
3/22	TOR	W 120-98	30	20	3	7	1	0	2	5	2	40.0%	10	6	60.0%	15	8	53.3%	2	2	100.0%	1	2	3.5	+15	3	22	63.0%
3/21	MIL	L 108-105	35	24	3	2	0	0	2	6	3	50.0%	11	6	54.5%	17	9	52.9%	7	3	42.9%	1	2	1.0	-14	1	21	59.8%
3/19	SAS	L 101-100	33	17	8	4	0	1	3	7	1	14.3%	13	6	46.2%	20	7	35.0%	2	2	100.0%	1	7	1.3	-5	1	14	40.7%
3/17	MIN	L 116-104	26	9	1	5	1	2	1	6	2	33.3%	11	1	9.1%	17	3	17.6%	2	1	50.0%	0	1	5.0	-3	0	0	25.2%
3/16	BOS	L 120-112	33	21	7	1	0	0	1	7	1	14.3%	13	7	53.8%	20	8	40.0%	4	4	100.0%	1	6	1.0	-12	1	16	48.3%
3/13	TOR	L 122-115	35	34	5	4	0	1	3	16	8	50.0%	9	5	55.6%	25	13	52.0%	0	0	0.0%	0	5	1.3	-2	1	29	68.0%
3/12	IND	W 123-108	34	36	3	4	0	4	5	9	3	33.3%	14	11	78.6%	23	14	60.9%	7	5	71.4%	0	3	0.8	+16	2	34	69.0%
3/10	MIL	W 129-114	32	25	4	5	0	0	3	10	3	30.0%	10	7	70.0%	20	10	50.0%	2	2	100.0%	0	4	1.7	+8	1	22	59.9%
3/8	CHA	W 111-99	29	24	4	2	0	1	3	10	4	40.0%	9	4	44.4%	19	8	42.1%	6	4	66.7%	0	4	0.7	+13	1	17	55.5%
3/6	NOP	W 118-116	30	25	5	3	0	0	2	9	3	33.3%	8	5	62.5%	17	8	47.1%	7	6	85.7%	0	5	1.5	+3	2	23	62.3%
3/5	CHI	L 105-103	31	12	3	3	0	1	1	8	1	12.5%	12	4	33.3%	20	5	25.0%	2	1	50.0%	0	3	3.0	-5	1	1	28.7%
3/3	SAC	W 114-103	31	20	4	1	1	4	7	8	2	25.0%	8	5	62.5%	16	7	43.8%	4	4	100.0%	0	4	0.1	+8	1	17	56.3%
2/26	LAL	W 113-110	23	9	3	1	0	1	4	7	1	14.3%	8	3	37.5%	15	4	26.7%	0	0	0.0%	0	3	0.3	-2	2	4	30.0%
2/24	BOS	L 97-81	25	13	4	1	0	0	1	8	1	12.5%	10	4	40.0%	18	5	27.8%	2	2	100.0%	2	2	1.0	-33	1	2	34.4%
2/22	POR	L 92-77	22	13	3	1	0	3	1	7	1	14.3%	9	5	55.6%	16	6	37.5%	0	0	0.0%	0	3	1.0	-6	1	9	40.6%
2/21	ORL	W 113-110	36	16	7	5	0	3	1	11	2	18.2%	15	4	26.7%	26	6	23.1%	6	2	33.3%	3	4	5.0	+0	3	1	27.9%
2/19	SAS	L 121-94	26	26	3	2	0	3	3	9	4	44.4%	14	7	50.0%	23	11	47.8%	0	0	0.0%	0	3	0.7	-20	1	16	56.5%
2/10	DAL	W 120-111	20	12	1	4	0	0	2	8	2	25.0%	6	3	50.0%	14	5	35.7%	0	0	0.0%	0	1	2.0	-6	0	4	42.9%
2/7	PHI	L 109-103	16	8	3	3	0	0	1	3	0	0.0%	3	2	66.7%	6	2	33.3%	4	4	100.0%	0	3	3.0	+7	0	11	51.5%
1/30	CLE	W 126-113	15	11	4	1	0	1	2	7	3	42.9%	2	1	50.0%	9	4	44.4%	0	0	0.0%	0	4	0.5	+7	1	11	61.1%
1/23	ATL	L 110-103	4	4	1	1	0	0	1	1	0	0.0%	2	1	50.0%	3	1	33.3%	2	2	100.0%	0	1	1.0	+4	0	4	51.5%
1/20	PHI	W 116-110	19	12	2	3	0	0	2	4	2	50.0%	7	2	28.6%	11	4	36.4%	2	2	100.0%	0	2	1.5	+10	1	7	50.5%
11/8	LAC	W 114-103	6	2	1	1	0	0	0	1	0	0.0%	2	1	50.0%	3	1	33.3%	0	0	0.0%	1	0	0.0	+7	1	1	33.3%
11/6	LAC	W 115-102	22	29	3	3	0	2	2	13	6	46.2%	7	4	57.1%	20	10	50.0%	5	3	60.0%	1	2	1.5	+30	1	26	65.3%
Regular Season Totals			25.9	17.8	3.6	2.8	0.3	1.1	2.3	7.1	2.2	31.3%	8.9	4.5	50.9%	16.0	6.8	42.2%	2.7	2.0	74.7%	0.5	3.1	1.3	+32	1.3	15.9	51.6%

Jalen Green: Breaking News

Green finished with 35 points (14-29 FG, 2-7 3Pt, 5-6 FT), five rebounds, two assists and one block across 35 minutes in Tuesday's 114-110 loss to the Trail Blazers in the Play-In Tournament. Green carried the Suns offensively in a game where Devin Booker was held to 7-for-17 shooting from the field, and the former delivered his best scoring mark of the entire 2025-26 campaign. Green will need to be at his best again when the Suns play in the final game of the Play-In Tournament on Friday, either against the Warriors or Clippers.

Green (knee) has been cleared to play in Tuesday's Play-In Game against the Trail Blazers. Green was held out for the final two matchups of the regular season due to a knee issue, but it won't prevent him from suiting up Tuesday. He should be back in the starting lineup in his return, which would bump Amir Coffey back to a bench role.

Green (knee) is listed as out for Sunday's game against Oklahoma City, Steve McGehee of News 9 Oklahoma City reports. Green will miss a second consecutive game before presumably returning for the Play-In Tournament. As a result, Jamaree Bouyea is in line for an enhanced role, potentially even entering the starting lineup.